Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patients

Autor: Arriagada R, Jean-Pierre PIGNON, Dc, Ihde, Dh, Johnson, Mc, Perry, Rl, Souhami, Brodin O, Ra, Joss, Ms, Kies, Lebeau B

Publikováno v: Europe PubMed Central

This meta-analysis was designed to evaluate the hypothesis that thoracic radiotherapy contributes to a moderate increase in overall survival in limited small-cell lung cancer. We collected individual data on all patients enrolled before December 1988

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bc1ab43e44c9652e49760ba4d48b04cf
https://pubmed.ncbi.nlm.nih.gov/8166478

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532.

Autor: Perry MC; Division of Hematology/Oncology, Room 524, University of Missouri/Ellis Fischel Cancer Center, 115 Business Loop 70 W, Columbia, MO, USA. perrym@health.missouri.edu, Ihde DC, Herndon JE 2nd, Grossbard ML, Grethein SJ, Atkins JN, Vokes EE, Green MR

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2000 Apr; Vol. 28 (1), pp. 63-8.

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.

Autor: Longo DL; Medicine Branch, Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA., Glatstein E, Duffey PL, Young RC, Ihde DC, Bastian AW, Wilson WH, Wittes RE, Jaffe ES, Hubbard SM, DeVita VT Jr

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1997 Nov; Vol. 15 (11), pp. 3338-46.

Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.

Autor: Cortazar P; National Cancer Institute-Navy Medical Oncology Branch, Biostatistics and Data Management Section, National Naval Medical Center, Bethesda, Maryland 20889-5105, USA., Gazdar AF, Woods E, Russell E, Steinberg SM, Williams J, Ihde DC, Johnson BE

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 1997 May; Vol. 3 (5), pp. 741-7.

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

Autor: Johnson BE; National Cancer Institute-Navy Medical Oncology, National Naval Medical Center Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Bridges JD, Sobczeck M, Gray J, Linnoila RI, Gazdar AF, Hankins L, Steinberg SM, Edison M, Frame JN, Pass H, Nesbitt J, Holden D, Mulshine JL, Glatstein E, Ihde DC

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1996 Mar; Vol. 14 (3), pp. 806-13.